Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
ICIs demonstrate robust efficacy and manageable toxicity in real-world settings, supporting their use in both first- and later-line treatments for advanced BTC. However, whether domestic ICI alternatives remain viable options warranting further validation.
Authors
- Jiamin Guo
- Dan Cao (ORCID: https://orcid.org/0000-0002-6709-4932)
- Yichen Zheng (ORCID: https://orcid.org/0000-0001-7998-0272)
- Ji Ma (ORCID: https://orcid.org/0000-0003-4486-2641)
- Tianhui Ren (ORCID: https://orcid.org/0000-0003-4369-9678)
Institutions
- Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.3389/fimmu.2025.1493234
- Citations
- 4
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Key Research and Development Program of Sichuan Province